Innovative product portfolio based on TELA Bio's proven technology platform advances the design of biologic-based materials for reconstructive surgery.

The Mesothelioma Compensation Center is incredibly passionate about making certain that a person who was exposed to asbestos at any type of nuclear power plant and now has mesothelioma or asbestos exposure lung cancer receives the very best possible financial compensation.

BD BACTEC™ Platelet Quality Control Media is cleared by the U.S. Food and Drug Administration and CE-IVD marked for platelet testing

Just approved for OTC use in the U.S. market, Tremotyx is now available in the U.S market after its successful launch in Germany.

Flash therapy preclinical results presented at AACR

Renown Health, northern Nevada's healthcare leader and Reno's only locally owned not-for-profit health system, and Genome Medical, a leading nationwide telegenomics technology and services company, today announced a partnership to bring genetic counseling and educational services to participants of the Healthy Nevada Project.

For Second Year, Company Will Serve as Kidney Walk National Presenting Sponsor

Results presented as oral presentation at 45th Annual Meeting of European Society for Blood and Marrow Transplantation

Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today it has partnered with The University of VermontMedical Center to help advance the network's specialty and ambulatory pharmacy services.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the first patient has been successfully dosed in a Phase IIa clinical study of IBI306, a recombinant fully human anti-proprotein convertase substilisin/kexin type 9 (anti-PCSK9) monoclonal antibody, for the treatment of hypercholesterolemia.

VESALIUS-CV is the Latest Study in Amgen's PROFICIO Clinical Program Investigating the Impact of Repatha on CVD in Multiple Patient Populations

Cornerstone Healthcare Group ("Cornerstone"), a diversified healthcare company with operations in the specialty hospital, senior living, and behavioral health fields, announced two new partnerships, expanding its capabilities into home health and strengthening its operations in the long-term acute care space.

Technology has caught up enough with Transcranial Magnetic Stimulation (TMS) and Repetitive transcranial magnetic stimulation (rTMS) that wearable brain stimulation technologies are on the market, developers of the innovative devices says.

Applications Seek to Extend Use of BOTOX® for Patients 2 to 17 Years Old

Azmi Nasser, D.O., Medical Director at Arizona Pain Treatment Centers in Arizona, sends his best regards to the patients and team affected from the closure of Laser Spine Institute (LSI) in Scottsdale, Arizona. Each patient preparing for surgery with LSI and now in need of care will be welcomed. Laser spine surgery is offered by Dr. Nasser and his team is here to help.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801) today announced that the first patient has been dosed in ORIENT-32, a trial that evaluates Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody, in combination with IBI305, a recombinant humanized anti-vascular endothelial growth factor (anti-VEGF) monoclonal antibody, as first-line treatment for patients with advanced hepatocellular carcinoma (HCC).

New diagnostic criteria reduce hospital admissions and stress testing without increasing risk of heart damage

Several citizens and organizations commented on an increased fear of diseases stemming from pollution related to hog farming in the area at the first of two meetings held by the North Carolina Department of Environmental Quality (DEQ) on proposed changes to three general animal operations permits.

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovarian cancer trial.

Clinical Study Shows That VR Intervention Improves Sleep, Quality of Life